![Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/44717/deaths_crude_prostate-1.png)
Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/predict-prostate-screengrab.jpg)
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
David Spiegelhalter on Twitter: "Predict Prostate launched today! https://t.co/E6f9hh0sTY - good to be linked from the Sun https://t.co/tA1sciElIN https://t.co/27EJmLcHdm" / Twitter
![Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/50828/cases_crude_prostate_1_2011_2013.jpg)
Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK
![Seoul National University prostate cancer calculator (Version 1.1). (A)... | Download Scientific Diagram Seoul National University prostate cancer calculator (Version 1.1). (A)... | Download Scientific Diagram](https://www.researchgate.net/profile/Sang-Lee-107/publication/261444002/figure/fig6/AS:667222758420496@1536089710820/Seoul-National-University-prostate-cancer-calculator-Version-11-A-Main-entry-page_Q640.jpg)
Seoul National University prostate cancer calculator (Version 1.1). (A)... | Download Scientific Diagram
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1b.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy](https://www.mdpi.com/jpm/jpm-09-00019/article_deploy/html/images/jpm-09-00019-g001.png)
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
![PDF) Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App PDF) Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App](https://www.researchgate.net/profile/Nuno-Pereira-Azevedo/publication/312410487/figure/fig4/AS:667646974504973@1536190851928/Screenshots-of-the-Rotterdam-Prostate-Cancer-Risk-Calculator-app-showing-About_Q320.jpg)
PDF) Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies](https://www.mdpi.com/ijms/ijms-24-02449/article_deploy/html/images/ijms-24-02449-g001.png)
IJMS | Free Full-Text | Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/034af9cccc61ea5eaf376b54f4f5f7a90ec04dca-765x477.png?fit=crop&auto=format)